#BEGIN_DRUGCARD DB03403

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
84-52-6

# ChEBI_ID:
17361

# Chemical_Formula:
C9H14N3O8P

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Cytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&#39;, 3&#39; or 5&#39; position. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Cytidine-5'-Monophosphate

# HET_ID:
C25

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7+,8+/m0/s1

# InChI_Key:
InChIKey=IERHLVCPSMICTF-ZAKLUEHWSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00055

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3403

# Mechanism_Of_Action:
Not Available

# Melting_Point:
233 dec Â°C

# Molecular_Weight_Avg:
323.1965

# Molecular_Weight_Mono:
323.051850951

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1RO8

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2

# Predicted_LogS:
-1.3

# Predicted_Water_Solubility:
1.63e+01 g/l

# Primary_Accession_No:
DB03403

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5745914

# PubChem_Substance_ID:
46505057

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00796

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC(=O)N(C=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:13 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AL111168

# Drug_Target_1_GenBank_ID_Protein:
112360903

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ispDF

# Drug_Target_1_Gene_Sequence:
>1116 bp
ATGAGTGAAATGAGCCTCATTATGTTAGCAGCTGGAAATTCTACTCGTTTTAATACAAAG
GTAAAAAAACAATTTTTACGACTTGGAAATGACCCTCTTTGGCTTTATGCAACAAAAAAT
TTAAGCTCTTTTTATCCTTTTAAAAAAATAGTTGTTACCTCTAGTAATATCACTTATATG
AAAAAATTTACCAAAAACTATGAATTCATAGAAGGTGGTGATACCAGAGCAGAATCCTTA
AAAAAAGCCTTAGAGCTCATAGATAGCGAATTTGTTATGGTAAGTGATGTAGCAAGGGTA
TTGGTGAGTAAAAATTTGTTTGATCGTTTGATTGAAAATTTAGATAAAGCAGATTGTATT
ACCCCTGCTTTAAAAGTTGCAGATACAACACTTTTTGACAATGAAGCCTTGCAAAGAGAA
AAAATCAAACTCATTCAAACCCCGCAAATTTCTAAAACCAAATTGCTTAAAAAAGCCTTG
GATCAAAACCTAGAATTTACAGATGATAGCACAGCTATAGCTGCAATGGGTGGAAAAATT
TGGTTTGTTGAAGGTGAAGAAAATGCAAGAAAACTAACCTTTAAAGAAGATCTTAAAAAA
CTTGATTTGCCTACACCTAGCTTTGAAATTTTTACTGGCAATGGTTTTGATGTGCATGAA
TTTGGAGAGAATCGCCCTTTGCTTTTAGCAGGAGTGCAAATTCATCCTACTATGGGGCTT
AAAGCACACAGCGATGGAGATGTTTTAGCTCACTCTTTAACCGATGCGATTTTAGGTGCT
GCAGGACTTGGAGATATAGGAGAGCTTTATCCTGATACTGATATGAAATTTAAAAATGCC
AACTCCATGGAGCTTTTAAAACAAGCTTATGATAAAGTCAGAGAAATAGGTTTTGAACTC
ATTAATATAGACATTTGCGTCATGGCACAAAGCCCTAAACTTAAAGACTTTAAACAAGCT
ATGCAAAGCAATATAGCTCATACTTTAGATTTAGATGAATTTAGAATCAATGTTAAAGCC
ACAACAACGGAAAAATTGGGTTTTATTGGAAGAAAAGAAGGTATGGCGGTGCTTAGTAGT
GTAAATTTAAAATATTTTGATTGGACAAGATTATGA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
10688204	Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AH, Whitehead S, Barrell BG: The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature. 2000 Feb 10;403(6770):665-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3188

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
41691

# Drug_Target_1_Name:
IspD/ispF bifunctional enzyme [Includes: 2-C-methyl-D-erythritol 4- phosphate cytidylyltransferase

# Drug_Target_1_Number_of_Residues:
371

# Drug_Target_1_PDB_ID:
1W57

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01128	IspD
PF02542	YgbB

# Drug_Target_1_Protein_Sequence:
>IspD/ispF bifunctional enzyme [Includes: 2-C-methyl-D-erythritol 4- phosphate cytidylyltransferase
MSEMSLIMLAAGNSTRFNTKVKKQFLRLGNDPLWLYATKNLSSFYPFKKIVVTSSNITYM
KKFTKNYEFIEGGDTRAESLKKALELIDSEFVMVSDVARVLVSKNLFDRLIENLDKADCI
TPALKVADTTLFDNEALQREKIKLIQTPQISKTKLLKKALDQNLEFTDDSTAIAAMGGKI
WFVEGEENARKLTFKEDLKKLDLPTPSFEIFTGNGFDVHEFGENRPLLLAGVQIHPTMGL
KAHSDGDVLAHSLTDAILGAAGLGDIGELYPDTDMKFKNANSMELLKQAYDKVREIGFEL
INIDICVMAQSPKLKDFKQAMQSNIAHTLDLDEFRINVKATTTEKLGFIGRKEGMAVLSS
VNLKYFDWTRL

# Drug_Target_1_Reaction:
CTP + 2-C-methyl-D-erythritol 4-phosphate = diphosphate + 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Bifunctional enzyme that catalyzes the formation of 4- diphosphocytidyl-2-C-methyl-D-erythritol from CTP and 2-C-methyl- D-erythritol 4-phosphate (MEP) (ispD), and converts 4- diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate into 2-C- methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and CMP (ispF)

# Drug_Target_1_SwissProt_ID:
Q9PM68

# Drug_Target_1_SwissProt_Name:
ISPDF_CAMJE

# Drug_Target_1_Synonyms:
2-C- methyl-D-erythritol 2,4-cyclodiphosphate synthase
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase;EC 2.7.7.60
4-diphosphocytidyl-2C- methyl-D-erythritol synthase
EC 4.6.1.12
MCT
MECDP-synthase
MECPS
MEP cytidylyltransferase

# Drug_Target_1_Theoretical_pI:
6.70

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Nucleus. Mainly nuclear. Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
CMPK

# Drug_Target_2_GenBank_ID_Gene:
AF070416

# Drug_Target_2_GenBank_ID_Protein:
6578133

# Drug_Target_2_GeneCard_ID:
CMPK

# Drug_Target_2_Gene_Name:
CMPK1

# Drug_Target_2_Gene_Sequence:
>687 bp
ATGCTGAGCCGCTGCCGCAGCGGGCTGCTCCACGTCCTGGGCCTTAGCTTCCTGCTGCAG
ACCCGCCGGCCGATTCTCCTCTGCTCTCCACGTCTCATGAAGCCGCTGGTCGTGTTCGTC
CTCGGCGGCCCCGGCGCCGGCAAGGGGACCCAGTGCGCCCGCATCGTCGAGAAATATGGC
TACACACACCTTTCTGCAGGAGAGCTGCTTCGTGATGAAAGGAAGAACCCAGATTCACAG
TATGGTGAACTTATTGAAAAGTACATTAAAGAAGGAAAGATTGTACCAGTTGAGATAACC
ATCAGTTTATTAAAGAGGGAAATGGATCAGACAATGGCTGCCAATGCTCAGAAGAATAAA
TTCTTGATTGATGGGTTTCCAAGAAATCAAGACAACCTTCAAGGATGGAACAAGACCATG
GATGGGAAGGCAGATGTATCTTTCGTTCTCTTTTTTGACTGTAATAATGAGATTTGTATT
GAACGATGTCTTGAGAGGGGAAAGAGTAGTGGTAGGAGTGATGACAACAGAGAGAGCTTG
GAAAAGAGAATTCAGACCTACCTTCAGTCAACAAAGCCAATTATTGACTTATATGAAGAA
ATGGGGAAAGTCAAGAAAATAGATGCTTCTAAATCTGTTGATGAAGTTTTTGATGAAGTT
GTGCAGATTTTTGACAAGGAAGGCTAA

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
10931946	Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, Gu YJ, Huang CH, Li YB, Jiang CL, Fu G, Zhang QH, Gu BW, Dai M, Mao YF, Gao GF, Rong R, Ye M, Zhou J, Xu SH, Gu J, Shi JX, Jin WR, Zhang CK, Wu TM, Huang GY, Chen Z, Chen MD, Chen JL: Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9543-8.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.
8313870	Hughes GJ, Frutiger S, Paquet N, Pasquali C, Sanchez JC, Tissot JD, Bairoch A, Appel RD, Hochstrasser DF: Human liver protein map: update 1993. Electrophoresis. 1993 Nov;14(11):1216-22.

# Drug_Target_2_HGNC_ID:
HGNC:18170

# Drug_Target_2_HPRD_ID:
18258

# Drug_Target_2_ID:
702

# Drug_Target_2_Locus:
1p32

# Drug_Target_2_Molecular_Weight:
22223

# Drug_Target_2_Name:
UMP-CMP kinase

# Drug_Target_2_Number_of_Residues:
196

# Drug_Target_2_PDB_ID:
1TEV

# Drug_Target_2_Pathway:
Gemcitabine Pathway	SMP00446

# Drug_Target_2_Pfam_Domain_Function:
PF00406	ADK

# Drug_Target_2_Protein_Sequence:
>UMP-CMP kinase
MKPLVVFVLGGPGAGKGTQCARIVEKYGYTHLSAGELLRDERKNPDSQYGELIEKYIKEG
KIVPVEITISLLKREMDQTMAANAQKNKFLIDGFPRNQDNLQGWNKTMDGKADVSFVLFF
DCNNEICIERCLERGKSSGRSDDNRESLEKRIQTYLQSTKPIIDLYEEMGKVKKIDASKS
VDEVFDEVVQIFDKEG

# Drug_Target_2_Reaction:
ATP + (d)CMP = ADP + (d)CDP

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes specific phosphoryl transfer from ATP to UMP and CMP

# Drug_Target_2_SwissProt_ID:
P30085

# Drug_Target_2_SwissProt_Name:
KCY_HUMAN

# Drug_Target_2_Synonyms:
Cytidine monophosphate kinase
Cytidylate kinase
Deoxycytidylate kinase
EC 2.7.4.14
UMP/CMP kinase
UMP/CMPK
Uridine monophosphate kinase
Uridine monophosphate/cytidine monophosphate kinase

# Drug_Target_2_Theoretical_pI:
5.20

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AB082126

# Drug_Target_3_GenBank_ID_Protein:
19911566

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
ispF

# Drug_Target_3_Gene_Sequence:
>459 bp
ATGCGCATCGGCTACGGCGAGGACAGCCACCGCCTGGAGGAGGGGAGGCCGCTTTACCTC
TGCGGCCTCCTCATTCCAAGCCCCGTGGGGGCCCTGGCCCACTCCGATGGGGACGCCGCC
CTCCACGCCCTCACCGACGCCCTCCTTTCCGCCTACGGCCTTGGGGACATCGGCCTCCTC
TTCCCCGACACCGATCCCCGCTGGCGGGGCGAGCGGAGCGAGGTGTTTCTCCGGGAGGCC
CTCCGCCTCGTGGAAGCGCGGGGGGCGAAGCTGCTTCAGGCGAGCCTCGTCCTCACCCTG
GACCGGCCCAAGCTCGGCCCCCACCGCAAGGCCTTGGTGGACAGCCTATCCCGCCTCCTC
CGCCTTCCCCAGGACCGCATTGGCCTCACCTTCAAGACCTCGGAGGGCCTGGCGCCTTCC
CACGTCCAGGCCCGGGCGGTGGTGCTTCTGGATGGTTGA

# Drug_Target_3_General_Function:
Lipid transport and metabolism

# Drug_Target_3_General_References:
Not Available

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2937

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
16520

# Drug_Target_3_Name:
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase

# Drug_Target_3_Number_of_Residues:
152

# Drug_Target_3_PDB_ID:
1IV1

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02542	YgbB

# Drug_Target_3_Protein_Sequence:
>2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
MRIGYGEDSHRLEEGRPLYLCGLLIPSPVGALAHSDGDAALHALTDALLSAYGLGDIGLL
FPDTDPRWRGERSEVFLREALRLVEARGAKLLQASLVLTLDRPKLGPHRKALVDSLSRLL
RLPQDRIGLTFKTSEGLAPSHVQARAVVLLDG

# Drug_Target_3_Reaction:
2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate + CMP

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Converts 4-diphosphocytidyl-2-C-methyl-D-erythritol 2- phosphate into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and CMP

# Drug_Target_3_SwissProt_ID:
Q8RQP5

# Drug_Target_3_SwissProt_Name:
ISPF_THET8

# Drug_Target_3_Synonyms:
EC 4.6.1.12
MECDP-synthase
MECPS

# Drug_Target_3_Theoretical_pI:
7.73

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X00785

# Drug_Target_4_GenBank_ID_Protein:
42839

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
cmk

# Drug_Target_4_Gene_Sequence:
>684 bp
ATGACGGCAATTGCCCCGGTTATTACCATTGATGGCCCAAGCGGTGCAGGGAAAGGCACC
TTGTGTAAGGCTATGGCGGAAGCGTTGCAATGGCATCTGCTGGACTCGGGTGCAATTTAT
CGCGTACTGGCATTGGCGGCATTACATCACCATGTTGATGTTGCGTCGGAAGATGCGCTG
GTACCGCTGGCATCCCATCTGGATGTACGTTTTGTGTCGACCAATGGCAATCTGGAAGTG
ATCCTCGAAGGGGAAGATGTCAGCGGCGAAATTCGTACTCAGGAAGTGGCGAATGCAGCT
TCACAAGTCGCGGCATTCCCACGCGTTCGTGAAGCATTATTGCGTCGCCAACGCGCGTTT
CGCGAATTACCAGGTCTGATTGCCGATGGCCGCGACATGGGAACGGTGGTATTCCCTGAT
GCACCAGTGAAAATTTTCCTTGACGCCTCCTCGGAAGAACGTGCGCATCGCCGCATGCTA
CAGTTGCAGGTGAAGGGCTTTAGTGTTAACTTTGAGCGCCTTTTGGCCGAGATCAAAGAA
CGCGACGACCGCGATCGTAACCGAGCGGTAGCGCCACTGGTTCCGGCAGCCGATGCTTTA
GTGTTGGATTCCACCACCTTAAGCATTGAGCAAGTGATTGAAAAAGCGCTACAATACGCG
CGCCAGAAATTGGCTCTCGCATAA

# Drug_Target_4_General_Function:
Nucleotide transport and metabolism

# Drug_Target_4_General_References:
6281725	Schnier J, Isono K: The DNA sequence of the gene rpsA of Escherichia coli coding for ribosomal protein S1. Nucleic Acids Res. 1982 Mar 25;10(6):1857-65.
6384724	Pedersen S, Skouv J, Kajitani M, Ishihama A: Transcriptional organization of the rpsA operon of Escherichia coli. Mol Gen Genet. 1984;196(1):135-40.
7836281	Fricke J, Neuhard J, Kelln RA, Pedersen S: The cmk gene encoding cytidine monophosphate kinase is located in the rpsA operon and is required for normal replication rate in Escherichia coli. J Bacteriol. 1995 Feb;177(3):517-23.
8190075	Yamanaka K, Ogura T, Koonin EV, Niki H, Hiraga S: Multicopy suppressors, mssA and mssB, of an smbA mutation of Escherichia coli. Mol Gen Genet. 1994 Apr;243(1):9-16.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9126287	Schultz CP, Ylisastigui-Pons L, Serina L, Sakamoto H, Mantsch HH, Neuhard J, Barzu O, Gilles AM: Structural and catalytic properties of CMP kinase from Bacillus subtilis: a comparative analysis with the homologous enzyme from Escherichia coli. Arch Biochem Biophys. 1997 Apr 1;340(1):144-53.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9862805	Briozzo P, Golinelli-Pimpaneau B, Gilles AM, Gaucher JF, Burlacu-Miron S, Sakamoto H, Janin J, Barzu O: Structures of escherichia coli CMP kinase alone and in complex with CDP: a new fold of the nucleoside monophosphate binding domain and insights into cytosine nucleotide specificity. Structure. 1998 Dec 15;6(12):1517-27.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2909

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
24747

# Drug_Target_4_Name:
Cytidylate kinase

# Drug_Target_4_Number_of_Residues:
227

# Drug_Target_4_PDB_ID:
1KDT

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF02224	Cytidylate_kin

# Drug_Target_4_Protein_Sequence:
>Cytidylate kinase
MTAIAPVITIDGPSGAGKGTLCKAMAEALQWHLLDSGAIYRVLALAALHHHVDVASEDAL
VPLASHLDVRFVSTNGNLEVILEGEDVSGEIRTQEVANAASQVAAFPRVREALLRRQRAF
RELPGLIADGRDMGTVVFPDAPVKIFLDASSEERAHRRMLQLQEKGFSVNFERLLAEIKE
RDDRDRNRAVAPLVPAADALVLDSTTLSIEQVIEKALQYARQKLALA

# Drug_Target_4_Reaction:
ATP + (d)CMP = ADP + (d)CDP

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
ATP, dATP, and GTP are equally effective as phosphate donors. CMP and dCMP are the best phosphate acceptors

# Drug_Target_4_SwissProt_ID:
P0A6I0

# Drug_Target_4_SwissProt_Name:
KCY_ECOLI

# Drug_Target_4_Synonyms:
CK
CMP kinase
Cytidine monophosphate kinase
EC 2.7.4.14
Protein mssA
p25

# Drug_Target_4_Theoretical_pI:
5.65

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
UCK2

# Drug_Target_5_GenBank_ID_Gene:
D78335

# Drug_Target_5_GenBank_ID_Protein:
1655420

# Drug_Target_5_GeneCard_ID:
UCK2

# Drug_Target_5_Gene_Name:
UCK2

# Drug_Target_5_Gene_Sequence:
>786 bp
ATGGCCGGGGACAGCGAGCAGACCCTGCAGAACCACCAGCAGCCCAACGGCGGCGAGCCC
TTCCTTATAGGCGTCAGCGGGGGAACAGCTAGCGGCAAGTCTTCCGTGTGTGCTAAGATC
GTGCAGCTCCTGGGGCAGAATGAGGTGGACTATCGCCAGAAGCAGGTGGTCATCCTGAGC
CAGGATAGCTTCTACCGTGTCCTTACCTCGGAGCAGAAGGCCAAAGCCCTGAAGGGCCAG
TTCAACTTTGACCACCCGGATGCCTTTGACAATGAACTCATTCTCAAAACACTCAAAGAA
ATCACTGAAGGGAAAACAGTCCAGATCCCCGTGTATGACTTTGTCTCCCATTCCCGGAAG
GAGGAGACAGTTACTGTCTATCCCGCAGACGTGGTGCTCTTTGAAGGGATCCTGGCCTTC
TACTCCCAGGAGGTACGAGACCTGTTCCAGATGAAGCTTTTTGTGGATACAGATGCGGAC
ACCCGGCTCTCACGCAGAGTATTAAGGGACATCAGCGAGAGAGGCAGGGATCTTGAGCAG
ATTTTATCTCAGTACATTACGTTCGTCAAGCCTGCCTTTGAGGAATTCTGCTTGCCAACA
AAGAAGTATGCTGATGTGATCATCCCTAGAGGTGCAGATAATCTGGTGGCCATCAACCTC
ATCGTGCAGCACATCCAGGACATCCTGAATGGAGGGCCCTCCAAACGGCAGACCAATGGC
TGTCTCAACGGCTACACCCCTTCACGCAAGAGGCAGGCATCGGAGTCCAGCAGCAGGCCG
CATTGA

# Drug_Target_5_General_Function:
Nucleotide transport and metabolism

# Drug_Target_5_General_References:
11306702	Van Rompay AR, Norda A, Linden K, Johansson M, Karlsson A: Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol. 2001 May;59(5):1181-6.
11494055	Koizumi K, Shimamoto Y, Azuma A, Wataya Y, Matsuda A, Sasaki T, Fukushima M: Cloning and expression of uridine/cytidine kinase cDNA from human fibrosarcoma cells. Int J Mol Med. 2001 Sep;8(3):273-8.
8812458	Ozaki K, Kuroki T, Hayashi S, Nakamura Y: Isolation of three testis-specific genes (TSA303, TSA806, TSA903) by a differential mRNA display method. Genomics. 1996 Sep 1;36(2):316-9.

# Drug_Target_5_HGNC_ID:
HGNC:12562

# Drug_Target_5_HPRD_ID:
01882

# Drug_Target_5_ID:
2697

# Drug_Target_5_Locus:
1q23

# Drug_Target_5_Molecular_Weight:
29299

# Drug_Target_5_Name:
Uridine-cytidine kinase 2

# Drug_Target_5_Number_of_Residues:
261

# Drug_Target_5_PDB_ID:
1XRJ

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00485	PRK

# Drug_Target_5_Protein_Sequence:
>Uridine-cytidine kinase 2
MAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILS
QDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRK
EETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQ
ILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNG
CLNGYTPSRKRQASESSSRPH

# Drug_Target_5_Reaction:
ATP + uridine = ADP + UMP

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Phosphorylates uridine and cytidine to uridine monophosphate and cytidine monophosphate. Does not phosphorylate deoxyribonucleosides or purine ribonucleosides. Can use ATP or GTP as a phosphate donor. Can also phosphorylate cytidine and uridine nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4- thiouridine, 5-bromouridine, 4-N-acetylcytidine, 4-N- benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5- methylcytidine, and 4-N-anisoylcytidine

# Drug_Target_5_SwissProt_ID:
Q9BZX2

# Drug_Target_5_SwissProt_Name:
UCK2_HUMAN

# Drug_Target_5_Synonyms:
Cytidine monophosphokinase 2
EC 2.7.1.48
UCK 2
Uridine monophosphokinase 2

# Drug_Target_5_Theoretical_pI:
6.68

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X74567

# Drug_Target_6_GenBank_ID_Protein:
397407

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
kpsU

# Drug_Target_6_Gene_Sequence:
>741 bp
ATGAGCAAAGCAGTTATTGTCATTCCGGCTCGCTATGGCTCCTCGCGCCTGCCGGGTAAG
CCACTGCTCGATATTGTTGGTAAACCGATGATCCAGCATGTTTACGAGCGTGCGTTACAG
GTGGCGGGCGTTGCGGAAGTTTGGGTGGCAACAGACGATCCGCGTGTTGAACAGGCCGTA
CAGGCGTTTGGCGGGAAAGCCATCATGACGCGCAACGATCATGAATCCGGCACCGATCGG
CTGGTCGAGGTGATGCATAAAGTCGAGGCAGATATCTACATTAACCTGCAGGGCGACGAA
CCAATGATTCGCCCGCGGGATGTAGAAACGCTGCTACAAGGAATGCGTGACGATCCCGCG
TTGCCGGTGGCAACGCTATGCCACGCGATTTCTGCCGCAGAAGCGGCTGAGCCAAGCACG
GTAAAAGTGGTTGTGAATACCCGCCAGGATGCGCTTTATTTCAGCCGCTCACCGATTCCG
TATCCGCGTAATGCTGAAAAAGCGCGCTACCTGAAACACGTCGGTATTTACGCTTATCGT
CGCGATGTGCTGCAAAACTACAGCCAGTTACCGGAGTCCATGCCGGAGCAGGCGGAATCA
CTGGAGCAGCTAAGGTTGATGAACGCGGGGATCAACATCCGCACATTTGAGGTTGCCGCA
ACCGGTCCGGGCGTCGACACCCCAGCATGCCTGGAAAAAGTGCGCGCCCTGATGGCACAG
GAACTGGCTGAAAACGCATGA

# Drug_Target_6_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_6_General_References:
7875563	Rosenow C, Roberts IS, Jann K: Isolation from recombinant Escherichia coli and characterization of CMP-Kdo synthetase, involved in the expression of the capsular K5 polysaccharide (K-CKS). FEMS Microbiol Lett. 1995 Jan 15;125(2-3):159-64.
8397187	Pazzani C, Rosenow C, Boulnois GJ, Bronner D, Jann K, Roberts IS: Molecular analysis of region 1 of the Escherichia coli K5 antigen gene cluster: a region encoding proteins involved in cell surface expression of capsular polysaccharide. J Bacteriol. 1993 Sep;175(18):5978-83.
8706906	Jelakovic S, Jann K, Schulz GE: The three-dimensional structure of capsule-specific CMP: 2-keto-3-deoxy-manno-octonic acid synthetase from Escherichia coli. FEBS Lett. 1996 Aug 5;391(1-2):157-61.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2765

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
27159

# Drug_Target_6_Name:
3-deoxy-manno-octulosonate cytidylyltransferase

# Drug_Target_6_Number_of_Residues:
246

# Drug_Target_6_PDB_ID:
1GQC

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF02348	CTP_transf_3

# Drug_Target_6_Protein_Sequence:
>3-deoxy-manno-octulosonate cytidylyltransferase
MSKAVIVIPARYGSSRLPGKPLLDIVGKPMIQHVYERALQVAGVAEVWVATDDPRVEQAV
QAFGGKAIMTRNDHESGTDRLVEVMHKVEADIYINLQGDEPMIRPRDVETLLQGMRDDPA
LPVATLCHAISAAEAAEPSTVKVVVNTRQDALYFSRSPIPYPRNAEKARYLKHVGIYAYR
RDVLQNYSQLPESMPEQAESLEQLRLMNAGINIRTFEVAATGPGVDTPACLEKVRALMAQ
ELAENA

# Drug_Target_6_Reaction:
CTP + 3-deoxy-D-manno-octulosonate = diphosphate + CMP-3-deoxy-D-manno-octulosonate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Activates KDO (a required 8-carbon sugar) for incorporation into bacterial lipopolysaccharide in Gram-negative bacteria

# Drug_Target_6_SwissProt_ID:
P42216

# Drug_Target_6_SwissProt_Name:
KPSU5_ECOLX

# Drug_Target_6_Synonyms:
CKS
CMP-2-keto-3-deoxyoctulosonic acid synthetase
CMP-KDO synthetase
EC 2.7.7.38

# Drug_Target_6_Theoretical_pI:
5.70

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AE005674

# Drug_Target_7_GenBank_ID_Protein:
24053164

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
ispF

# Drug_Target_7_Gene_Sequence:
>480 bp
TCATTTTGTTGCCTTAATGAGTAGCGCCACCGCTTCACAGGCAATCCCTTCCCCACGTCC
GGTAAATCCAAGTTTTTCCGTAGTAGTGGCTTTCACGTTAACATCATCCATATGGCAGCC
GAGATCTTCGGCAATAAACACGCGCATTTGTGGAATGTGCGGCAACATCTTCGGTGCCTG
AGCGATGATAGTGACATCGACGTTGCCAAGGGTATAACCCTTCGCCTGAATACGACGCCA
GGCTTCGCGTAGCAGCTCGCGGCTGTCGGCACCTTTAAATGCCGGATCGGTATCCGGGAA
CAGTTTGCCGATATCCCCCAGCGCCGCCGCGCCAAGCAATGCATCGGTCAACGCATGAAG
CGCCACGTCGCCATCAGAATGCGCCAGCAATCCTTTTTCGTAAGGAATGCGTACGCCACC
AATGATAATTGGGCCTTCACCGCCAAAGGCGTGTACGTCAAAACCGTGTCCAATTCGCAT

# Drug_Target_7_General_Function:
Lipid transport and metabolism

# Drug_Target_7_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
2383

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
16898

# Drug_Target_7_Name:
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase

# Drug_Target_7_Number_of_Residues:
159

# Drug_Target_7_PDB_ID:
1U43

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF02542	YgbB

# Drug_Target_7_Protein_Sequence:
>2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
MRIGHGFDVHAFGGEGPIIIGGVRIPYEKGLLAHSDGDVALHALTDALLGAAALGDIGKL
FPDTDPAFKGADSRELLREAWRRIQAKGYTLGNVDVTIIAQAPKMLPHIPQMRVFIAEDL
GCHMDDVNVKATTTEKLGFTGRGEGIACEAVALLIKATK

# Drug_Target_7_Reaction:
2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate + CMP

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Converts 4-diphosphocytidyl-2-C-methyl-D-erythritol 2- phosphate into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and CMP

# Drug_Target_7_SwissProt_ID:
P62619

# Drug_Target_7_SwissProt_Name:
ISPF_SHIFL

# Drug_Target_7_Synonyms:
EC 4.6.1.12
MECDP-synthase
MECPS

# Drug_Target_7_Theoretical_pI:
6.51

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AF130984

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
cst-II

# Drug_Target_8_Gene_Sequence:
Not Available

# Drug_Target_8_General_Function:
Not Available

# Drug_Target_8_General_References:
10660542	Gilbert M, Brisson JR, Karwaski MF, Michniewicz J, Cunningham AM, Wu Y, Young NM, Wakarchuk WW: Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis. J Biol Chem. 2000 Feb 11;275(6):3896-906.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
3779

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
34545

# Drug_Target_8_Name:
Alpha-2,3/8-sialyltransferase

# Drug_Target_8_Number_of_Residues:
291

# Drug_Target_8_PDB_ID:
1RO7

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF06002	CST-I

# Drug_Target_8_Protein_Sequence:
>Alpha-2,3/8-sialyltransferase
MKKVIIAGNGPSLKEIDYSRLPNDFDVFRCNQFYFEDKYYLGKKCKAVFYNPILFFEQYY
TLKHLIQNQEYETELIMCSNYNQAHLENENFVKTFYDYFPDAHLGYDFFKQLKDFNAYFK
FHEIYFNQRITSGVYMCAVAIALGYKEIYLSGIDFYQNGSSYAFDTKQKNLLKLAPNFKN
DNSHYIGHSKNTDIKALEFLEKTYKIKLYCLCPNSLLANFIELAPNLNSNFIIQEKNNYT
KDILIPSSEAYGKFSKNINFKKIKIKENIYYKLIKDLLRLPSDIKHYFKGK

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
Q9LAK3

# Drug_Target_8_SwissProt_Name:
Q9LAK3_CAMJE

# Drug_Target_8_Synonyms:
Alpha-2,3-/2,8-sialyltransferase

# Drug_Target_8_Theoretical_pI:
9.02

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
L10328

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
coaBC

# Drug_Target_9_Gene_Sequence:
Not Available

# Drug_Target_9_General_Function:
Coenzyme transport and metabolism

# Drug_Target_9_General_References:
6139280	Lundberg LG, Thoresson HO, Karlstrom OH, Nyman PO: Nucleotide sequence of the structural gene for dUTPase of Escherichia coli K-12. EMBO J. 1983;2(6):967-71.
7686882	Burland V, Plunkett G 3rd, Daniels DL, Blattner FR: DNA sequence and analysis of 136 kilobases of the Escherichia coli genome: organizational symmetry around the origin of replication. Genomics. 1993 Jun;16(3):551-61.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
3692

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
43439

# Drug_Target_9_Name:
Coenzyme A biosynthesis bifunctional protein coaBC

# Drug_Target_9_Number_of_Residues:
406

# Drug_Target_9_PDB_ID:
Not Available

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF02441	Flavoprotein
PF04127	DFP

# Drug_Target_9_Protein_Sequence:
>Coenzyme A biosynthesis bifunctional protein coaBC
MSLAGKKIVLGVSGGIAAYKTPELVRRLRDRGADVRVAMTEAAKAFITPLSLQAVSGYPV
SDSLLDPAAEAAMGHIELGKWADLVILAPATADLIARVAAGMANDLVSTICLATPAPVAV
LPAMNQQMYRAAATQHNLEVLASRGLLIWGPDSGSQACGDIGPGRMLDPLTIVDMAVAHF
SPVNDLKHLNIMITAGPTREPLDPVRYISNHSSGKMGFAIAAAAARRGANVTLVSGPVSL
PTPPFVKRVDVMTALEMEAAVNASVQQQNIFIGCAAVADYRAATVAPEKIKKQATQGDEL
TIKMVKNPDIVAGVAALKDHRPYVVGFAAETNNVEEYARQKRIRKNLDLICANDVSQPTQ
GFNSDNNALHLFWQDGDKVLPLERKELLGQLLLDEIVTRYDEKNRR

# Drug_Target_9_Reaction:
CTP + (R)-4'-phosphopantothenate + L-cysteine = CMP + diphosphate + N-[(R)-4'-phosphopantothenoyl]-L-cysteine

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Catalyzes two steps in the biosynthesis of coenzyme A. In the first step cysteine is conjugated to 4'-phosphopantothenate to form 4-phosphopantothenoylcysteine, in the latter compound is decarboxylated to form 4'-phosphopantotheine

# Drug_Target_9_SwissProt_ID:
P0ABQ0

# Drug_Target_9_SwissProt_Name:
COABC_ECOLI

# Drug_Target_9_Synonyms:
CoaB]
CoaC
DNA/pantothenate metabolism flavoprotein[Includes: Phosphopantothenoylcysteine decarboxylase
EC 4.1.1.36
EC 6.3.2.5
PPC synthetase
PPCDC
PPCS
Phosphopantothenate-- cysteine ligase
Phosphopantothenoylcysteine synthase

# Drug_Target_9_Theoretical_pI:
7.58

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03403
